Get started
Author

Elżbieta Bylina

Observed names: E. Bylina, ELZBIETA BYLINA, Elzbieta Bylina
ORCID: 0000-0001-6479-1815
Observed ORCID: 0000-0001-6479-1815
OpenAlex ID: A5066619943
Neoadjuvant Imatinib in Locally Advanced Gastrointestinal Stromal Tumors (GIST): The EORTC STBSG Experience
2013 · Piotr Rutkowski, Alessandro Gronchi, et al. · Annals of Surgical Oncology · 248
Tumor Genotype Is an Independent Prognostic Factor in Primary Gastrointestinal Stromal Tumors of Gastric Origin: A European Multicenter Analysis Based on ConticaGIST
2014 · Agnieszka Wozniak, Piotr Rutkowski, et al. · Clinical Cancer Research · 175
PDF
Validation of the Joensuu risk criteria for primary resectable gastrointestinal stromal tumour – The impact of tumour rupture on patient outcomes
2011 · P. Rutkowski, E. Bylina, et al. · European Journal of Surgical Oncology · 173
Prognostic value of KIT/PDGFRA mutations in gastrointestinal stromal tumours (GIST): Polish Clinical GIST Registry experience
2011 · A. Wozniak, P. Rutkowski, et al. · Annals of Oncology · 166
The outcome and predictive factors of sunitinib therapy in advanced gastrointestinal stromal tumors (GIST) after imatinib failure - one institution study
2012 · Piotr Rutkowski, Elżbieta Bylina, et al. · BMC Cancer · 90
PDF
Chondrosarcoma-from Molecular Pathology to Novel Therapies
2021 · Agnieszka E. Zając, Sylwia Kopeć, et al. · Cancers · 89
PDF
The Megavoltage Radiation Therapy in Treatment of Patients With Advanced or Difficult Giant Cell Tumors of Bone
2009 · Wlodzimierz Ruka, Piotr Rutkowski, et al. · International Journal of Radiation Oncology*Biology*Physics · 77
Clinical, Pathological and Surgical Characteristics of Duodenal Gastrointestinal Stromal Tumor and Their Influence on Survival: A Multi-Center Study
2012 · C. Colombo, U. Ronellenfitsch, et al. · Annals of Surgical Oncology · 69
Quality of treatment and surgical approach for rectal gastrointestinal stromal tumour (GIST) in a large European cohort
2020 · Nikki S. IJzerman, Mahmoud Mohammadi, et al. · European Journal of Surgical Oncology · 43
PDF
Merkel Cell Carcinoma from Molecular Pathology to Novel Therapies
2021 · Karolina Stachyra, Monika Dudzisz-Śledź, et al. · International Journal of Molecular Sciences · 42
PDF
Melanoma without a Detectable Primary Site with Metastases to Lymph Nodes
2010 · PIOTR RUTKOWSKI, ZBIGNIEW I. NOWECKI, et al. · Dermatologic Surgery · 42
Interpretable artificial intelligence to optimise use of imatinib after resection in patients with localised gastrointestinal stromal tumours: an observational cohort study
2024 · Dimitris Bertsimas, Georgios Antonios Margonis, et al. · The Lancet Oncology · 33
PDF
What are the current outcomes of advanced gastrointestinal stromal tumors: who are the long-term survivors treated initially with imatinib?
2013 · Piotr Rutkowski, Jolanta Andrzejuk, et al. · Medical Oncology · 30
PDF
An interpretable AI model for recurrence prediction after surgery in gastrointestinal stromal tumour: an observational cohort study
2023 · Dimitris Bertsimas, Georgios Antonios Margonis, et al. · EClinicalMedicine · 27
PDF
From Molecular Biology to Novel Immunotherapies and Nanomedicine in Uveal Melanoma
2024 · Kamil J. Synoradzki, Natalia Paduszyńska, et al. · Current Oncology · 23
PDF
The analysis of the long-term outcomes of sorafenib therapy in routine practice in imatinib and sunitinib resistant gastrointestinal stromal tumors (GIST)*
2017 · Piotr Rutkowski, Beata Jagielska, et al. · Współczesna Onkologia · 20
PDF
Cutaneous melanoma with nodal metastases in elderly people
2010 · Piotr Rutkowski, Zbigniew I. Nowecki, et al. · International Journal of Dermatology · 19
Blood neutrophil-to-lymphocyte ratio is associated with prognosis in advanced gastrointestinal stromal tumors treated with imatinib
2018 · Piotr Rutkowski, Paweł Teterycz, et al. · Tumori Journal · 18
Treatment outcomes in older patients with advanced gastrointestinal stromal tumor (GIST)
2018 · Piotr Rutkowski, Elżbieta Bylina, et al. · Journal of Geriatric Oncology · 18
The analysis of 3-year adjuvant therapy with imatinib in patients with high-risk molecular profiled gastrointestinal stromal tumors (GIST) treated in routine practice
2020 · Piotr Rutkowski, Marcin Ziętek, et al. · European Journal of Surgical Oncology · 17
The analysis of the outcomes and factors related to iliac–obturator involvement in cutaneous melanoma patients after lymph node dissection due to positive sentinel lymph node biopsy or clinically detected inguinal metastases
2013 · M. Zdzienicki, P. Rutkowski, et al. · European Journal of Surgical Oncology · 14
Treatment of Gastrointestinal Stromal Tumors (GISTs): A Focus on Younger Patients
2022 · Monika Dudzisz-Śledź, Anna Klimczak, et al. · Cancers · 11
PDF
Treatment of Metastatic Gastrointestinal Stromal Tumors (GIST): A Focus on Older Patients
2021 · Monika Dudzisz-Śledź, Elżbieta Bylina, et al. · Drugs & Aging · 11
PDF
Prognostic value of the pretreatment neutrophil‑to‑lymphocyte ratio in patients with advanced gastrointestinal stromal tumors treated with sunitinib after imatinib failure
2019 · Paweł Sobczuk, Paweł Teterycz, et al. · Oncology Letters · 6
1667TiP A phase II, single arm study of avelumab in combination with axitinib in patients with unresectable/metastatic gastrointestinal stromal tumor after failure of standard therapy - AXAGIST
2020 · K. Kozak, M.A. Pantaleo, et al. · Annals of Oncology · 5
Works count: 56
Citation count: 1,484
H-index: 18
I10-index: 23
Year
Topic
Type